About 1 million people in the U.S. live with multiple sclerosis (MS). When I first heard that number, it felt like a cold statistic; today, it feels like a community. While MS has redrawn the boundaries of my physical world, it has failed to shrink the borders of my spirit. My story is not about…
Month: March 2026
New CSF protein markers may help support multiple sclerosis diagnosis
A test that measures a specific set of proteins in cerebrospinal fluid (CSF) — the liquid that surrounds the brain and spinal cord — may help support the diagnosis of multiple sclerosis (MS), a new study shows. The approach could be particularly useful for people who lack a common CSF diagnostic marker known as oligoclonal…
Largest Art Showcase Ever Debuts, plus MSAA’s March 2026 Artist of the Month
For more than 15 years, MSAA has celebrated the artistic talents of the MS community in our digital Art Showcase. This year – for the second year in a row – we are excited to launch MSAA’s largest Showcase to … Continue reading → Source: blog.mymsaa.org
Caring for others while living with MS requires finding balance
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like this, using the hashtag #MSAwarenessMonth, or read the full series….
Loss of nerve communication a feature if MS
Tweet Loss of nerves is a marker for disability but one of the earlier features in loss of the connections between nerves call synapses. It was shown by ProfK and the gang. Petrova N, Nutma E, Carassiti D, Rs Newman J, Amor S, Altmann DR, Baker D, Schmierer K. Synaptic Loss in Multiple Sclerosis Spinal…
Fenebrutinib again bests Aubagio in trial at cutting MS relapse rates
Fenebrutinib, Genentech’s investigational BTK inhibitor, was found to significantly reduce relapse rates compared with the approved therapy Aubagio (teriflunomide) in two Phase 3 clinical trials involving people with relapsing forms of multiple sclerosis (MS). Positive top-line results from one of those trials, FENhance 2 (NCT04586023), were announced late last year. Now, Genentech has reported that…
I don’t have to be an Olympic medalist to achieve remarkable things
Growing up, athleticism was part of my identity. To a degree, I measured myself by what I was physically capable of doing. I was constantly driven to test my limits, always aiming for higher, stronger, and more daring. I’m still in awe at what the human body is capable of. This February, I watched the…
How MS Australia’s 2026 Main Grants Round is advancing MS research
The post How MS Australia’s 2026 Main Grants Round is advancing MS research appeared first on MS Australia. Source: www.msaustralia.org.au
Scientists take major step toward changing the course of multiple sclerosis
The post Scientists take major step toward changing the course of multiple sclerosis appeared first on MS Australia. Source: www.msaustralia.org.au
New study links specific MRI lesion pattern to MS risk before symptoms
A specific pattern of damage seen on MRI scans, called a paramagnetic rim lesion, is associated with a higher risk of developing overt multiple sclerosis (MS) in people who have MS-like brain lesions but no symptoms, according to a new study. This condition is known as radiologically isolated syndrome (RIS), which refers to people who…